Sustained reduction of aldosterone in response to the angiotensin receptor blocker valsartan in patients with chronic heart failure: results from the Valsartan Heart …
JN Cohn, IS Anand, R Latini, S Masson, YT Chiang… - Circulation, 2003 - Am Heart Assoc
Background—Aldosterone has been implicated in the progression of heart failure. The
Valsartan Heart Failure Trial (Val-HeFT) provided the first opportunity to examine the long …
Valsartan Heart Failure Trial (Val-HeFT) provided the first opportunity to examine the long …
[引用][C] Sustained reduction of aldosterone in response to the angiotensin receptor blocker Valsartan in patients with chronic heart failure results from the Valsartan …
JN COHN, IS ANAND, R LATINI… - … (New York, NY), 2003 - pascal-francis.inist.fr
Sustained reduction of aldosterone in response to the angiotensin receptor blocker Valsartan
in patients with chronic heart failure results from the Valsartan Heart Failure trial CNRS Inist …
in patients with chronic heart failure results from the Valsartan Heart Failure trial CNRS Inist …
Sustained reduction of aldosterone in response to the angiotensin receptor blocker valsartan in patients with chronic heart failure: results from the Valsartan Heart …
JN Cohn, IS Anand, R Latini, S Masson, YT Chiang… - Circulation, 2003 - europepmc.org
Background Aldosterone has been implicated in the progression of heart failure. The
Valsartan Heart Failure Trial (Val-HeFT) provided the first opportunity to examine the long …
Valsartan Heart Failure Trial (Val-HeFT) provided the first opportunity to examine the long …
Sustained reduction of aldosterone in response to the angiotensin receptor blocker Valsartan in patients with chronic heart failure: Results from the Valsartan heart …
JN Cohn, IS Anand, R Latini, S Masson, YT Chiang… - Circulation, 2003 - experts.umn.edu
Background-Aldosterone has been implicated in the progression of heart failure. The
Valsartan Heart Failure Trial (Val-HeFT) provided the first opportunity to examine the long …
Valsartan Heart Failure Trial (Val-HeFT) provided the first opportunity to examine the long …
Sustained reduction of aldosterone in response to the angiotensin receptor blocker valsartan in patients with chronic heart failure: results from the Valsartan Heart …
JN Cohn, IS Anand, R Latini, S Masson… - …, 2003 - pubmed.ncbi.nlm.nih.gov
Background Aldosterone has been implicated in the progression of heart failure. The
Valsartan Heart Failure Trial (Val-HeFT) provided the first opportunity to examine the long …
Valsartan Heart Failure Trial (Val-HeFT) provided the first opportunity to examine the long …
[引用][C] Sustained Reduction of Aldosterone in Response to the Angiotensin Receptor Blocker Valsartan in Patients With Chronic Heart Failure
JN Cohn, IS Anand, R Latini, S Masson, YT Chiang… - Circulation, 2003 - cir.nii.ac.jp
Sustained Reduction of Aldosterone in Response to the Angiotensin Receptor Blocker
Valsartan in Patients With Chronic Heart Failure | CiNii Research CiNii 国立情報学研究所 学術 …
Valsartan in Patients With Chronic Heart Failure | CiNii Research CiNii 国立情報学研究所 学術 …
[PDF][PDF] Sustained Reduction of Aldosterone in Response to the Angiotensin Receptor Blocker Valsartan in Patients With Chronic Heart Failure
JN Cohn, IS Anand, R Latini, S Masson - Circulation, 2003 - Citeseer
Background—Aldosterone has been implicated in the progression of heart failure. The
Valsartan Heart Failure Trial (Val-HeFT) provided the first opportunity to examine the long …
Valsartan Heart Failure Trial (Val-HeFT) provided the first opportunity to examine the long …
[PDF][PDF] Sustained Reduction of Aldosterone in Response to the Angiotensin Receptor Blocker Valsartan in Patients With Chronic Heart Failure
JN Cohn, IS Anand, R Latini, S Masson - Circulation, 2003 - academia.edu
Background—Aldosterone has been implicated in the progression of heart failure. The
Valsartan Heart Failure Trial (Val-HeFT) provided the first opportunity to examine the long …
Valsartan Heart Failure Trial (Val-HeFT) provided the first opportunity to examine the long …
[引用][C] Sustained reduction of aldosterone in response to the angiotensin receptor blocker valsartan in patients with chronic heart failure: results from the Valsartan …
C JN - Circulation, 2003 - cir.nii.ac.jp
Sustained reduction of aldosterone in response to the angiotensin receptor blocker valsartan
in patients with chronic heart failure : results from the Valsartan Heart Failure Trial | CiNii …
in patients with chronic heart failure : results from the Valsartan Heart Failure Trial | CiNii …